< Back to previous page
Researcher
Graciela Andrei
- Disciplines:Virology
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 15
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Dynamics of cytomegalovirus infection: evolution towards antiviral drug resistanceFrom1 Feb 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Challenges and opportunities in the management of herpes simplex virus antiviral resistanceFrom17 Apr 2018 → 17 Apr 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- IN SEARCH FOR SUGAR, BASE OR PHOSPHATE MODIFIED NUCLEOSIDES ACTIVE AGAINST RNA VIRUSESFrom30 Nov 2017 → 7 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unraveling the role of BK polyomavirus variants and of cellular CMP kinase on viral pathogenicity and clearance in renal-transplant patientsFrom1 Oct 2017 → 30 Sep 2021Funding: FWO Applied Biomedical Research (TBM)
- Automated real-time quantitative live cell analysisFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- MERKEL CELL CARCINOMA, TOWARDS THE IDENTIFICATION OF NOVEL MOLECULAR TARGETS AND THE ESTABLISHMENT OF A THREE-DIMENSIONAL CELL CULTURE MODELFrom9 Nov 2015 → 14 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Understanding gamma-herpesvirus pathogenesis and development of novel treatment strategies.From1 Aug 2014 → 3 Dec 2020Funding: FWO Strategic Basic Research Grant
- An automated platform for multiparameter data collection on live pathogens of higher or unknown biosafety risk.From26 Jun 2014 → 31 Dec 2018Funding: Hercules - Large scale research infrastructure
Publications
41 - 50 of 249
- Synthesis, characterization and biological evaluation of 1,3-thiazolidine-4-ones derived from (2S)-2-benzoylamino-3-methylbutanohydrazide hydrazones(2021)
Authors: Erik De Clercq, Graciela Andrei, Robert Snoeck, Christophe Pannecouque
Pages: 507 - 518 - MERKEL CELL CARCINOMA, TOWARDS THE IDENTIFICATION OF NOVEL MOLECULAR TARGETS AND THE ESTABLISHMENT OF A THREE-DIMENSIONAL CELL CULTURE MODEL(2020)
Authors: Arturo Jesús Temblador Pérez, Robert Snoeck, Graciela Andrei, Dimitrios Topalis
- Understanding γ-herpesvirus response to antiviral therapy(2020)
Authors: Erika Trompet, Graciela Andrei, Robert Snoeck
- Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues(2020)
Authors: Robert Snoeck, Graciela Andrei
- Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase(2020)
Authors: Erika Trompet, Dimitrios Topalis, Robert Snoeck, Graciela Andrei
- New acetamide derivatives containing (omega-p-bromophenoxyalkyl)uracil moiety and their anticytomegalovirus activity(2020)
Authors: Robert Snoeck, Graciela Andrei
Pages: 602 - 603 - Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs(2020)
Authors: Robert Snoeck, Graciela Andrei
Pages: 1088 - 1107 - Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties(2020)
Authors: Robert Snoeck, Graciela Andrei
- BKTyper: Free Online Tool for Polyoma BK Virus VP1 and NCCR Typing(2020)
Authors: Olga Mineeva-Sangwo, Dimitrios Topalis, Robert Snoeck, Graciela Andrei, Piet Maes
- Amidate Prodrugs of O-2-Alkylated Pyrimidine Acyclic Nucleosides Display Potent Anti-Herpesvirus Activity(2020)
Authors: Elisabetta Groaz, Robert Snoeck, Graciela Andrei, Piet Herdewyn
Pages: 1410 - 1415
Patents
1 - 6 of 6
- Prodrugs of nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)
- Novel purine derivatives and drugs comprising same (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)